Moderna Prices Its $1.3 Billion Share Sale to Fund Virus Vaccine

(Bloomberg) -- Moderna Inc. plans to raise as much as $1.3 billion through a sale of shares to fund manufacturing of a coronavirus vaccine seen as one of the frontrunners in the race for immunizati...